肛門癌治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Anal Cancer Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04695 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、肛門癌治療の世界市場について調査・分析し、肛門癌治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（フルオロウラシル、シスプラチン、カルボプラチン）、用途別（病院、長期ケアセンター、薬局、診断研究所）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の肛門癌治療市場動向 ・主要企業別マーケットシェア ・肛門癌治療の種類別市場規模2014-2019 （フルオロウラシル、シスプラチン、カルボプラチン） ・肛門癌治療の用途別市場規模2014-2019 （病院、長期ケアセンター、薬局、診断研究所） ・肛門癌治療の北米市場：主要企業・種類別/用途別市場規模 ・肛門癌治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・肛門癌治療の中国市場：主要企業・種類別/用途別市場規模 ・肛門癌治療の日本国内市場：主要企業・種類別/用途別市場規模 ・肛門癌治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・肛門癌治療のインド市場：主要企業・種類別/用途別市場規模 ・肛門癌治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GlaxoSmithKline Pharmaceuticals、Spectrum Pharmaceuticals、Hospira、Global BioPharma、Advaxis） ・肛門癌治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it may cause in the anal canal. This type of cancer is usually associated with human papiloma virus (HPV), where HPV cancers or cervical cancers have a high risk of developing into anal cancer. There are no exact symptoms for anal cancer as such but some might show bleeding from the anal area, lump or swelling near anus or change in the bowel habits etc.  Staging is a way which describes the location of cancer, the stages include tumor, node and metastasis which is further grouped I, II, IIIA, IIIB and IV. The different types of anal cancer include melanoma, adenocarcinoma, basaloid transitional and cloacogenic cancer.The statistics for anal cancer suggest that annually there about 6000 cases of anal cancer diagnosed in the U.S. and the number is increasing slowly. The major factors that drive the market for anal cancer therapeutics are aging population, sexually transmitted disease, multiple sexual partners and smoking. According to the World Health Organization 290 million women are suffering from HPV infection and due to unhealthy sex, the chances get doubled. For treating this anal cancer, early diagnosis is crucial which is only available in the developed countries or high-income countries and are accessible. Whereas in the low-income countries the diagnosis and treatment facilities are either costly or inaccessible. These factors are responsible for holding back the anal cancer therapeutics market and should be well tracked for future advancements.
In 2018, the global Anal Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Anal Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anal Cancer Therapeutics development in United States, Europe and China.

The key players covered in this study
GlaxoSmithKline Pharmaceuticals
Spectrum Pharmaceuticals
Hospira
Global BioPharma
Advaxis
…

Market segment by Type, the product can be split into
Fluorouracil
Cisplatin
Carboplatin

Market segment by Application, split into
Hospitals
Long-Term Care Centers
Pharmacies
Diagnostic Laboratories

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anal Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Anal Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anal Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anal Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Fluorouracil
1.4.3 Cisplatin
1.4.4 Carboplatin
1.5 Market by Application
1.5.1 Global Anal Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Long-Term Care Centers
1.5.4 Pharmacies
1.5.5 Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Anal Cancer Therapeutics Market Size
2.2 Anal Cancer Therapeutics Growth Trends by Regions
2.2.1 Anal Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Anal Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Anal Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Anal Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Anal Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Anal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Anal Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Anal Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Anal Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Anal Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Anal Cancer Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Anal Cancer Therapeutics Market Size (2014-2019)
5.2 Anal Cancer Therapeutics Key Players in United States
5.3 United States Anal Cancer Therapeutics Market Size by Type
5.4 United States Anal Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Anal Cancer Therapeutics Market Size (2014-2019)
6.2 Anal Cancer Therapeutics Key Players in Europe
6.3 Europe Anal Cancer Therapeutics Market Size by Type
6.4 Europe Anal Cancer Therapeutics Market Size by Application

7 China
7.1 China Anal Cancer Therapeutics Market Size (2014-2019)
7.2 Anal Cancer Therapeutics Key Players in China
7.3 China Anal Cancer Therapeutics Market Size by Type
7.4 China Anal Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Anal Cancer Therapeutics Market Size (2014-2019)
8.2 Anal Cancer Therapeutics Key Players in Japan
8.3 Japan Anal Cancer Therapeutics Market Size by Type
8.4 Japan Anal Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Anal Cancer Therapeutics Market Size (2014-2019)
9.2 Anal Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Anal Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Anal Cancer Therapeutics Market Size by Application

10 India
10.1 India Anal Cancer Therapeutics Market Size (2014-2019)
10.2 Anal Cancer Therapeutics Key Players in India
10.3 India Anal Cancer Therapeutics Market Size by Type
10.4 India Anal Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Anal Cancer Therapeutics Market Size (2014-2019)
11.2 Anal Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Anal Cancer Therapeutics Market Size by Type
11.4 Central & South America Anal Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline Pharmaceuticals
12.1.1 GlaxoSmithKline Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anal Cancer Therapeutics Introduction
12.1.4 GlaxoSmithKline Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2014-2019)
12.1.5 GlaxoSmithKline Pharmaceuticals Recent Development
12.2 Spectrum Pharmaceuticals
12.2.1 Spectrum Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anal Cancer Therapeutics Introduction
12.2.4 Spectrum Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2014-2019)
12.2.5 Spectrum Pharmaceuticals Recent Development
12.3 Hospira
12.3.1 Hospira Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anal Cancer Therapeutics Introduction
12.3.4 Hospira Revenue in Anal Cancer Therapeutics Business (2014-2019)
12.3.5 Hospira Recent Development
12.4 Global BioPharma
12.4.1 Global BioPharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anal Cancer Therapeutics Introduction
12.4.4 Global BioPharma Revenue in Anal Cancer Therapeutics Business (2014-2019)
12.4.5 Global BioPharma Recent Development
12.5 Advaxis
12.5.1 Advaxis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anal Cancer Therapeutics Introduction
12.5.4 Advaxis Revenue in Anal Cancer Therapeutics Business (2014-2019)
12.5.5 Advaxis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Anal Cancer Therapeutics Key Market Segments
Table Key Players Anal Cancer Therapeutics Covered
Table Global Anal Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Anal Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure Fluorouracil Figures
Table Key Players of Fluorouracil
Figure Cisplatin Figures
Table Key Players of Cisplatin
Figure Carboplatin Figures
Table Key Players of Carboplatin
Table Global Anal Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Long-Term Care Centers Case Studies
Figure Pharmacies Case Studies
Figure Diagnostic Laboratories Case Studies
Figure Anal Cancer Therapeutics Report Years Considered
Table Global Anal Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Anal Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Anal Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Anal Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Anal Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Anal Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Anal Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Anal Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Anal Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Anal Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Anal Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Anal Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Anal Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Anal Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Anal Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Anal Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Anal Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Anal Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Anal Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Anal Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Anal Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Anal Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Anal Cancer Therapeutics Market Share (2018-2019)
Table United States Anal Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Anal Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Anal Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Anal Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Anal Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Anal Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Anal Cancer Therapeutics Market Share (2018-2019)
Table Europe Anal Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Anal Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Anal Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Anal Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Anal Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Anal Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Anal Cancer Therapeutics Market Share (2018-2019)
Table China Anal Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Anal Cancer Therapeutics Market Share by Type (2014-2019)
Table China Anal Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Anal Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Anal Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Anal Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Anal Cancer Therapeutics Market Share (2018-2019)
Table Japan Anal Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Anal Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Anal Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Anal Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Anal Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Anal Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Anal Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Anal Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Anal Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Anal Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Anal Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Anal Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Anal Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Anal Cancer Therapeutics Market Share (2018-2019)
Table India Anal Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Anal Cancer Therapeutics Market Share by Type (2014-2019)
Table India Anal Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Anal Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Anal Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Anal Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Anal Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Anal Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Anal Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Anal Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Anal Cancer Therapeutics Market Share by Application (2014-2019)
Table GlaxoSmithKline Pharmaceuticals Company Details
Table GlaxoSmithKline Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Anal Cancer Therapeutics Business (2014-2019)
Table GlaxoSmithKline Pharmaceuticals Recent Development
Table Spectrum Pharmaceuticals Company Details
Table Spectrum Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Spectrum Pharmaceuticals Revenue Growth Rate in Anal Cancer Therapeutics Business (2014-2019)
Table Spectrum Pharmaceuticals Recent Development
Table Hospira Company Details
Table Hospira Revenue in Anal Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Hospira Revenue Growth Rate in Anal Cancer Therapeutics Business (2014-2019)
Table Hospira Recent Development
Table Global BioPharma Company Details
Table Global BioPharma Revenue in Anal Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Global BioPharma Revenue Growth Rate in Anal Cancer Therapeutics Business (2014-2019)
Table Global BioPharma Recent Development
Table Advaxis Company Details
Table Advaxis Revenue in Anal Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Advaxis Revenue Growth Rate in Anal Cancer Therapeutics Business (2014-2019)
Table Advaxis Recent Development
Table Global Anal Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Anal Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Anal Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Anal Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Anal Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Anal Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Anal Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Anal Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Anal Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Anal Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Anal Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Anal Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Anal Cancer Therapeutics Market Size by Product in 2025
Table Global Anal Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Anal Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Anal Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---